- Carlyle Group (CG) is preparing $3.7B in financing that will back its purchase of Johnson & Johnson's (JNJ) ortho clinical diagnostics unit in a deal expected to be signed by the end of this week, Reuters reports.
- Including equity and $3.3B in funded debt, sources peg the offer price in the $4.1B-$4.5B range.
- Reports last month said Carlyle was nearing a ~$4B deal for the unit; the P-E firm's exclusivity period on the deal is said to end Jan. 17.
Reuters: Carlyle lines up financing for J&J diagnostics unit
Jan 13 2014, 17:08 ET